(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






Health Care Sector

Novartis receives FDA approval for expanded use of Zykadia(R) in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)

May 26th, 2017

* In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared to 8.1 months with chemotherapy[1] * The overall intracranial response rate in patients with measurable brain metastases was 57% . Read more

Diplomat to Dispense KEVZARA(R) for Treatment of Rheumatoid Arthritis

May 25th, 2017

The nation’s largest independent specialty pharmacy has been selected as a preferred pharmacy for the drug KEVZARA® (sarilumab) for rheumatoid arthritis. FLINT, Mich. / CRWE PRESS RELEASE / May 25, 2017 - Diplomat Pharmacy, Inc. (NYSE: D. Read more

Puma Biotechnology Announces Publication of Neratinib Abstract for the 2017 ASCO Annual Meeting

May 17th, 2017

LOS ANGELES, Calif. / CRWE PRESS RELEASE / May 17, 2017 - Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced the release of an abstract on its drug candidate PB272 (neratinib) that will be presented at the American S. Read more

Nature's Sunshine Products Receives Direct Selling License in China

May 16th, 2017

LEHI, Utah / CRWE PRESS RELEASE / May 16, 2017 - Nature’s Sunshine Products (NASDAQ: NATR), “the Company”, a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal . Read more

Merus Labs and Norgine Enter into a Definitive Arrangement Agreement

May 11th, 2017

* Norgine to acquire all outstanding shares of Merus for $1.65 per share in cash TORONTO, ONTARIO and AMSTERDAM, NETHERLANDS / CRWE PRESS RELEASE / May 11 , 2017 - Merus Labs International Inc. ("Merus" or the "Company") TSX: MSL, NASDAQ: MSLI and. Read more

Bovie Medical Receives 510K Clearance for its J-Plasma(R) Precise Flex Handpiece

May 08th, 2017

The Addition of the J-Plasma® Precise Flex rounds out Bovie Medical’s J-Plasma® offering to include products designed for open and minimally invasive surgical procedures, including laparoscopic and robotic approaches. CLEARWATER, FL . Read more

VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study

May 02nd, 2017

Cambridge, Massachusetts / CRWE PRESS RELEASE / May 2, 2017 - VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (“VBI”) today provided an update on its cytomegalovirus (“CMV”) Phase I clinical study, which is assessing the safety an. Read more

Kitov Pharmaceuticals Files 6-K with Update on Israeli Securities Authority Investigation

May 01st, 2017

TEL AVIV, Israel / CRWE PRESS RELEASE / May 1, 2017 - Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, today filed a 6-K with an update on the ongoing Israeli Securities Authority Investigation.. Read more

Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize PIXUVRI(R)

April 25th, 2017

• Servier will commercialize PIXUVRI in all markets except the US • CTI BioPharma will retain rights to commercialize PIXUVRI in the US Paris, France and Seattle, Washington / CRWE PRESS RELEASE / April 25, 2017 – Servier and CTI . Read more

Cancer Genetics, Inc. Launches a Unique, Industry-Leading Panel That Provides Comprehensive & Precise Information for Immuno-Oncology Therapy Assessment & Patient Monitoring

April 24th, 2017

* Complete::IO™ provides immune endpoint and immune monitoring of patients allowing informed therapeutic decisions and assessment of potential toxicities of IO therapies in blood cancers and solid tumors * Complete::IO™ can determine pre. Read more

Auris Medical Reports Key Results from Keyzilen(R) AMPACT2 Open-Label Extension Study

April 24th, 2017

* Trial outcomes show positive safety profile of Keyzilen® for chronic intermittent use * Exploratory efficacy results support therapeutic concept of early tinnitus treatment Zug, Switzerland / CRWE PRESS RELEASE / April 24, 2017 - Auris Medi. Read more

Load More Content